Annual Report

Overview

The report presents 2018 Group revenue of HK$2,093.7 million, up 55.8% year on year, and notes profit of HK$71.5 million. The company completed the acquisition of Tongfang Pharmaceutical's remaining 40% equity interest, making it an indirect wholly-owned subsidiary. Its ESG report covers medical, pharmaceutical and health, fitness, and cement businesses, with environmental protection and product responsibility identified as key aspects. The report also describes solar power, waste-reduction, and resource-efficiency initiatives across operations.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2018
Period: Ends 31 December 2018
Publication date: 29 March 2019
Language: English, Chinese
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services